Michael Nelson

Title: Michael Nelson: Innovator in Drug Monitoring Technology

Introduction

Michael Nelson is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of drug monitoring technology, holding a total of 2 patents. His innovative work focuses on improving patient safety and therapeutic outcomes through advanced monitoring tools.

Latest Patents

One of Michael Nelson's latest patents is a drug monitoring tool that comprises a data receiver and an interactive user interface. This tool is designed to receive a pharmacokinetic (PK) profile of a patient. The interactive user interface displays a time-varying therapeutic plasma protein level of the patient and delineates various zones associated with this level. These zones include a safe zone, indicating that the plasma protein level is within a safe concentration range for physical activity, and a danger zone, which alerts the patient that the level is within a range that requires limited physical activity. Another patent also relates to a drug monitoring tool with similar features, emphasizing the importance of monitoring therapeutic plasma protein levels based on administered doses.

Career Highlights

Throughout his career, Michael Nelson has worked with notable companies in the pharmaceutical industry, including Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in developing innovative drug monitoring solutions.

Collaborations

Michael has collaborated with several professionals in his field, including Gerald Spotts and Roman Pichler. These collaborations have further enhanced his work and contributed to the development of effective monitoring tools.

Conclusion

Michael Nelson is a prominent inventor whose work in drug monitoring technology has the potential to significantly improve patient care. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.